StockData
Zura Bio Ltd logo

Zura Bio Ltd (ZURA) stock

ZURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 5/30
$0.93−0.02 (-2.30%)

Close on Nov 20, 2026Market cap $89.63MP/E –Yield –

Zura Bio operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Zura Bio's operating cash flow for the twelve months ending Sep 30, 2026 was -$64.83M. For fiscal 2025 it was -$64.82M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$64.82M–
FY2024Dec 31, 2024-$28.08M–
FY2023Dec 31, 2023-$15.05M–
FY2022Dec 31, 2022-$1.07M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$19.50K–
Q2 FY2026Jun 30, 2026$18.88M+71.1%
Q1 FY2026Mar 31, 2026-$18.92M–
Q4 FY2025Dec 31, 2025-$64.77M–
Q3 FY2025Sep 30, 2025-$15.44K–
Q2 FY2025Jun 30, 2025$11.04M–
Q1 FY2025Mar 31, 2025-$11.06M–
Q4 FY2024Dec 31, 2024-$10.82M–
Q3 FY2024Sep 30, 2024-$5.65M–
Q2 FY2024Jun 30, 2024-$6.62M–
Q1 FY2024Mar 31, 2024-$4.98M–
Q4 FY2023Dec 31, 2023-$4.05M–
Q3 FY2023Sep 30, 2023-$2.57M–
Q2 FY2023Jun 30, 2023-$5.17M–
Q1 FY2023Mar 31, 2023-$3.26M–
Q4 FY2022Dec 31, 2022-$116.28K–
Q3 FY2022Sep 30, 2022-$267.26K–
Q2 FY2022Jun 30, 2022-$472.88K–
Q1 FY2022Mar 31, 2022-$214.62K–

More Zura Bio figures

See a number that looks wrong?